Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Interim Statements of Cash Flows (Unaudited)

v3.20.4
Condensed Consolidated Interim Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities    
Loss for the period $ (24,931) $ (3,346)
Adjustments to reconcile net loss to net cash used in operating activities    
Amortization of intangible assets 2 6
In-process research and development 16,094  
Change in fair value of milestone liability (11)  
Amortization of deferred loan costs 51  
Interest expense 16  
Shares issued for services   8
Warrants issued for services 228 35
Stock option expense 2,530 211
Changes in operating assets and liabilities    
Prepaid expenses and deposits (2,785) 156
Interest, taxes and other receivables 1 (4)
Accounts payable and accrued liabilities (362) (994)
Related party payables (374) (49)
Net cash used in operating activities (9,541) (3,977)
Cash flows from investing activities    
Cash acquired on merger with Adgero 969  
Proceeds on sale of equipment 3  
Net cash provided by investing activities 972  
Cash flows from financing activities    
Net proceeds from the issuance of shares and warrants 21,638 6,583
Warrants exercised for cash 1,180 27
Stock options exercised for cash 21  
Proceeds from loan 500  
Series A preferred cash dividend (4) (4)
Net cash provided by financing activities 23,335 6,606
Decrease in cash and cash equivalents 14,766 2,629
Cash and cash equivalents – beginning of period 2,392 3,719
Cash and cash equivalents – end of period $ 17,158 $ 6,348